Table 1.
1. | Non-diabetic nephrotic syndrome |
2. | Non-ischemic cardiomyopathy and hypertrophy* |
3. | Hepatomegaly or increased alkaline phosphatase** |
4. | Monoclonal gammopathy with |
a. Autonomic or sensory neuropathy | |
b. Unexplained fatigue | |
c. Edema | |
d. Unintentional weight loss |
Signs and symptoms that may represent AL amyloidosis in a patient. Non-diabetic nephrotic syndrome; non-ischemic cardiomyopathy and hypertrophy on echocardiogram, especially in the absence of hypertension*; hepatomegaly or increased alkaline phosphatase with no liver abnormalities by imaging**; or autonomic neuropathy with orthostasis or sensory neuropathy with a monoclonal protein. In patients with monoclonal gammopathy and unexplained fatigue, edema, weight loss or paresthesias, AL amyloidosis should also be considered.